Clinical Trials Logo

Clinical Trial Summary

The study will evaluate the efficacy and safety of Broncho-munal®, capsules, 7 mg (Sandoz dd, Slovenia) versus Placebo in the treatment of patients with acute uncomplicated respiratory tract infections.


Clinical Trial Description

Patients who meet the inclusion criteria and do not meet the exclusion criteria will be randomized into 2 groups in a 1: 1 ratio. Group 1 (n = 278) will receive the study drug Broncho-munal®, capsules, 7 mg (Sandoz dd, Slovenia), Group 2 (n = 278) will receive a placebo ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05588804
Study type Interventional
Source Sandoz
Contact
Status Completed
Phase Phase 3
Start date November 7, 2022
Completion date December 18, 2022